The molecular basis of sulfonamide resistance in Toxoplasma gondii and implications for the clinical management of toxoplasmosis
- PMID: 12023770
- DOI: 10.1086/340577
The molecular basis of sulfonamide resistance in Toxoplasma gondii and implications for the clinical management of toxoplasmosis
Abstract
Polymerase chain reaction amplification and DNA sequencing of the Toxoplasma gondii dihydropteroate synthase gene (dhps) identified 4 alleles among parasite populations from 32 cases of human toxoplasmosis. Heterologous expression and enzyme assay reveal that 3 of these alleles encode sulfadiazine (Sdz)-sensitive enzymes. The fourth, generating a highly Sdz-resistant enzyme, differs from 1 of the other 3 at only a single residue (407) of DHPS. Of interest, a fifth allele, found in a laboratory-induced Sdz-resistant line, also differs from another of these 3 drug-sensitive forms by the same single mutation that affects residue 407 of DHPS. Significantly, residues corresponding to DHPS-407 are implicated in sulfonamide resistance in other microorganisms. The human-derived allelic form encoding the Sdz-resistant enzyme was found in T. gondii associated with a fatal infection, and its presence within clinical material may have implications for sulfonamide use, particularly in cases of toxoplasmosis in which the initial response to drug treatment is poor.
Similar articles
-
Genetic Polymorphisms and Phenotypic Profiles of Sulfadiazine-Resistant and Sensitive Toxoplasma gondii Isolates Obtained from Newborns with Congenital Toxoplasmosis in Minas Gerais, Brazil.PLoS One. 2017 Jan 24;12(1):e0170689. doi: 10.1371/journal.pone.0170689. eCollection 2017. PLoS One. 2017. PMID: 28118394 Free PMC article.
-
[Gene polymorphisms in the dihydrofolate reductase ( dhfr ) and dihydropteroate synthase ( dhps ) genes and structural modelling of the dhps gene in Colombian isolates of Toxoplasma gondii].Biomedica. 2014 Oct-Dec;34(4):556-66. doi: 10.1590/S0120-41572014000400008. Biomedica. 2014. PMID: 25504244 Spanish.
-
Isolation and molecular characterization of the bifunctional hydroxymethyldihydropterin pyrophosphokinase-dihydropteroate synthase gene from Toxoplasma gondii.Mol Biochem Parasitol. 1997 May;86(1):37-47. Mol Biochem Parasitol. 1997. PMID: 9178266
-
Resistance as a tool in the study of old and new drug targets in Toxoplasma.Drug Resist Updat. 2001 Apr;4(2):79-84. doi: 10.1054/drup.2001.0184. Drug Resist Updat. 2001. PMID: 11512524 Review.
-
Screening for small molecule inhibitors of Toxoplasma gondii.Expert Opin Drug Discov. 2012 Dec;7(12):1193-206. doi: 10.1517/17460441.2012.729036. Epub 2012 Sep 24. Expert Opin Drug Discov. 2012. PMID: 22998671 Review.
Cited by
-
Transient Adaptation of Toxoplasma gondii to Exposure by Thiosemicarbazone Drugs That Target Ribosomal Proteins Is Associated with the Upregulated Expression of Tachyzoite Transmembrane Proteins and Transporters.Int J Mol Sci. 2024 Aug 21;25(16):9067. doi: 10.3390/ijms25169067. Int J Mol Sci. 2024. PMID: 39201756 Free PMC article.
-
Anti-Toxoplasma gondii activity of rose hip oil-solid lipid nanoparticles.Food Sci Nutr. 2024 Feb 20;12(5):3725-3734. doi: 10.1002/fsn3.4043. eCollection 2024 May. Food Sci Nutr. 2024. PMID: 38726453 Free PMC article.
-
Analysis of random mutations in Salmonella Gallinarum dihydropteroate synthase conferring sulfonamide resistance.Arch Microbiol. 2023 Oct 31;205(12):363. doi: 10.1007/s00203-023-03696-5. Arch Microbiol. 2023. PMID: 37906281
-
Recent progress in vaccine development targeting pre-clinical human toxoplasmosis.Parasites Hosts Dis. 2023 Aug;61(3):231-239. doi: 10.3347/PHD.22097. Epub 2023 Aug 21. Parasites Hosts Dis. 2023. PMID: 37648228 Free PMC article.
-
Apicomplexans in Goat: Prevalence of Neospora caninum, Toxoplasma gondii, Cryptosporidium spp., Eimeria spp. and Risk Factors in Farms from Ecuador.Animals (Basel). 2022 Aug 29;12(17):2224. doi: 10.3390/ani12172224. Animals (Basel). 2022. PMID: 36077944 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical